Myriad Genetics, Inc. (MYGN) — Dilution Risk Analysis

Current Snapshot

Myriad Genetics, Inc. (MYGN) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Dilution Risk Score

Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: EFFECT 1, 424B3 1, 4 7, S-3 1.

Form	Filed	Accession
EFFECT	2026-03-04	9999999995-26-000727
424B3	2026-03-04	0000899923-26-000029
4	2026-03-02	0001472827-26-000002
4	2026-02-27	0001471518-26-000002
S-3	2026-02-24	0000899923-26-000020
4	2026-02-03	0001843872-26-000003
4	2026-02-03	0001922964-26-000004
4	2026-02-03	0001517026-26-000002
4	2026-02-03	0002082246-26-000002
4	2026-01-02	0001922964-26-000002

Dilution Risk Drivers

Driver	Stored Value	Source
Shelf registration capacity	$200,000,000	Source
ATM offering capacity remaining	$200,000,000	Source
Cash runway	16 months	Source
Three-year share count growth	16.36%	Source

DilutionWatch Analysis

Risk Level: MEDIUM (Score: 50/10) Source
Cash Runway: 16 months Source
ATM Offering Capacity Remaining: $200,000,000 Source
Shelf Registration Capacity: $200,000,000 Source
Share Count Growth (3-Year): 16.36% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.